Sotalol
Sotalol
Definition
An ethanolamine derivative with Class III antiarrhythmic and antihypertensive properties. Sotalol is a nonselective beta-adrenergic receptor and potassium channel antagonist. In the heart, this agent inhibits chronotropic and inotropic effects thereby slowing the heart rate and decreasing myocardial contractility. This agent also reduces sinus rate, slows conduction in the atria and in the atrioventricular (AV) node and increases the functional refractory period of the AV node.
Also known as SOTALOL — per NCIT
Also identified as
- ATC C07AA per NCIT
- NCIT NCIT:C61949 per NCIT
Indications
| Disease | Relation | Source |
|---|---|---|
| Atrial fibrillation | may prevent | MEDRT · Public domain (U.S. Government work) |
| Atrial flutter | may prevent | MEDRT · Public domain (U.S. Government work) |
| Atrial fibrillation | may treat | MEDRT · Public domain (U.S. Government work) |
| Atrial flutter | may treat | MEDRT · Public domain (U.S. Government work) |
| Ventricular fibrillation | may treat | MEDRT · Public domain (U.S. Government work) |
| Ventricular tachycardia | may treat | MEDRT · Public domain (U.S. Government work) |
Organ Effects
| Organ | Side effect / interaction | Source |
|---|---|---|
| Cardiovascular system | may treat a disease of this organ | DERIVED · CC BY 4.0 |
1 entry above is marked DERIVED: Atlas Médico inferred it by combining two sourced claims, and no source asserts this link directly. Treat it as a navigation aid, not as a clinical statement.